Mike Yost has retired as chief marketing officer of Indianapolis-based Indiana University Health. Mr. Yost joined the now-16-hospital system in 2009 after working in branding for pharma giant Eli ...
Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...
From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...
Forget about Herceptin. There’s a new HER2 agent that ought to be used in HER2-positive stomach cancer, and that’s Jazz ...
University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...
Eating clementines regularly can support your immune system and help prevent some chronic diseases, though overconsumption may have adverse effects.
Severe valvular heart disease was not uncommon among patients with cancer, and intervention to manage the valvular disease ...
A new meta-analysis further supports the previously reported link between kidney stones and an increased risk for kidney ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...
A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...
A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback